Pioglitazone - PowerPoint PPT Presentation

DYSLIPIDEMIAS: TYPES I-V

DYSLIPIDEMIAS: TYPES I-V. Thomas F. Whayne, Jr, MD, PhD, FACC Professor of Medicine (Cardiology) University of Kentucky March 2011. E-Mail: twhayn0@uky.edu . No conflicts to declare. THE MAJOR LIPOPROTEINS. CHYLOMICRONS. VERY LOW DENS. LIPOPROT. (VLDL).

★ ★ ★ ★ ★

1.04k views • 50 slides

Insulin Sensitizers: Surrogate and Clinical Outcomes Studies

Insulin Sensitizers: Surrogate and Clinical Outcomes Studies. Metformin improves endothelial function. Metformin 1000 mg ( 3 months). Placebo. 400. 350. *. 300. 250. Increase in forearm blood flow (%). 200. *. 150. 100. *. 50. 0. 3. 10. 30. 3. 10. 30.

★ ★ ★ ★ ★

473 views • 30 slides

Volume 366, Issue 9493, 8 October 2005-14 October 2005, Pages 1279-1289

Volume 366, Issue 9493, 8 October 2005-14 October 2005, Pages 1279-1289. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

★ ★ ★ ★ ★

311 views • 16 slides

View Pioglitazone PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Pioglitazone PowerPoint presentations. You can view or download Pioglitazone presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.